Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Steven W. Lefkowitz

At a glance: Steven W. Lefkowitz is Director at CorMedix (CRMD). Their latest SEC Form 4, filed Nov 20, 2026, reported a purchase of $52K. On file: 1 purchase line ($52K) and 1 sale line ($475K).

Disclosed holdings: about $692K of CRMD stock: 137,451 shares reported on their latest Form 4 (filed Nov 20, 2026), valued at the Nov 19, 2026 close of $5.04. This counts only CRMD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at CorMedix Inc. (CRMD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$6K
Total bought / sold$52K / $475K

Steven W. Lefkowitz's InsiderPrint

3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of Steven W. Lefkowitz: 3 trades, 2020 to 20262020: 1 buy, 0 sales2021: 0 buys, 0 sales2022: 0 buys, 0 sales2023: 0 buys, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 1 sale2026: 1 buy, 0 sales

Reading this print: Mostly buys, trading about once a year, typically $52K a trade; often buys after the stock has fallen 15% or more.

  • Bump outward: a purchase (2)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Tonya Williams BradfordDirector · LOB · 99% match
  2. Jacki Sue KelleyDirector · FRPT · 98% match
  3. Barclay CorbusCEO, President · CLNE · 98% match
  4. Carol Anthony DavidsonDirector · FMC · 96% match
  5. Philip N. GarfinkleDirector · WYY · 94% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2020

From the SEC's insider data sets: each open-market buy by Steven W. Lefkowitz, matched to how the stock did over the next 90 days against the S&P 500.

1 of 1 buy beat the S&P 500 (100%), median +78.3% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
CRMDSep 9, 2020+78.3%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 20 NewSEC CRMDCorMedix Inc.First buy in 6 yrs Buy 11,500137,451 held (+9%) $4.53 $52K —
Dec 10SEC CRMDCorMedix Inc. Sell 40,00080,498 held (−33%) $11.88 $475K -57.6%
  • Buy

    Director Steven W Lefkowitz bought $52K of CRMD at $4.53 — first open-market purchase in our records.

  • Sell

    Director Steven W Lefkowitz sold $475K of CRMD at $11.88 — cuts the stake by 33%.

Follow Steven W. Lefkowitz

Get one email when Steven W. Lefkowitz files a new purchase or sale. Free.

At most one email a day about Steven W. Lefkowitz, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.